Skip to main content

Table 6 Somatic mutations of nuclear genome in the plasma cfDNA of the training data set for the diagnosis of early-stage LUAD

From: Molecular fingerprints of nuclear genome and mitochondrial genome for early diagnosis of lung adenocarcinoma

 

AUC (μ, 95% CI) (%)

Sensitivity (%)

Specificity (%)

TT

70.00 (48.66–91.34)

83.33

60.00

CFT

60.67 (34.70–86.63)

33.33

84.00

HC

81.33 (66.57–96.10)

100.00

72.00

THF

73.00 (54.59–91.41)

83.33

56.00

CFHF

73.00 (51.91–94.09)

66.67

76.00

ALL

82.33 (68.04–96.63)

100.00

72.00

  1. TT: the selected genes whose mutations was associated with higher TMB in tumor tissues; CFT: the selected genes whose mutations was associated with higher TMB in cfDNA of LUAD patients; HC: the selected genes whose variation frequencies in tumor tissues and cfDNA were both > 25%; THF: the top five mutation genes in tumor tissues; CFHF: the top five mutation genes in cfDNA of LUAD patients; ALL: all the selected genes above